PCOS and Hair Fall: How Your Hormones Are Thinning Your Hair

Polycystic ovary syndrome affects approximately 1 in 5 Indian women of reproductive age — making it one of the most common hormonal conditions in the country. Yet its connection to hair fall is consistently underdiscussed, even by doctors. Most women who are told they have PCOS receive advice about irregular periods, insulin resistance, and acne. Hair loss, which affects 20–30% of women with PCOS, often goes unaddressed until the thinning becomes impossible to ignore.

Understanding why PCOS causes hair fall — and specifically how it differs from other types of hair loss — is the first step toward doing something that will actually work.

Why PCOS Causes Hair Fall: The DHT Mechanism

PCOS is characterised by hyperandrogenism — elevated levels of male hormones (androgens) in a female body. The most relevant androgen for hair fall is dihydrotestosterone (DHT).

DHT is produced when the enzyme 5-alpha reductase converts testosterone into DHT. In women with PCOS, increased androgen production means more testosterone available for this conversion — resulting in significantly elevated DHT levels at the scalp.

DHT binds to androgen receptors in the dermal papilla cells of hair follicles. In genetically susceptible follicles (primarily those at the crown and top of the scalp), this binding initiates follicle miniaturisation — a progressive process where the follicle shrinks over successive hair cycles, producing thinner and shorter hairs until eventually it stops producing terminal hair at all.

The result is female androgenetic alopecia — the female-specific pattern of DHT-driven hair thinning.

The Pattern Is Different — And It Matters for Diagnosis

This is where PCOS-related hair fall is most commonly misidentified.

Unlike telogen effluvium (which causes diffuse shedding across the whole scalp equally), PCOS-driven hair fall follows a specific topographic pattern: thinning concentrated at the crown and widened central part, with the frontal hairline typically preserved. It does not create the dramatic clumps or sudden shedding that telogen effluvium does — it is gradual and progressive, making it easy to dismiss as "just ageing" until significant thinning has occurred.

Additional diagnostic clues that distinguish PCOS hair fall from other types:

•     Occurs alongside other signs of hyperandrogenism: acne (particularly jawline and chin), irregular periods, excess facial or body hair (hirsutism)

•     Worsens around menstruation when hormonal fluctuations are most pronounced

•     Often affects the family — female relatives with similar patterns

The PCOS-Stress Compounding Effect

Women with PCOS frequently experience chronic psychological stress — driven by the condition itself, by its impact on body image and fertility, and by the frustration of navigating a health system where the condition is often undertreated. This matters for hair fall because stress elevates cortisol, which further disrupts the hormonal environment and can push additional follicles into telogen simultaneously.

The result is a double mechanism: DHT-driven miniaturisation at the follicle level and stress-driven telogen effluvium on top of it. Many women with PCOS experience both simultaneously — which is why their hair fall can seem disproportionately severe compared to what DHT alone would cause.

What to Do: The Evidence-Based Approach

Step 1: Confirm the diagnosis

If you suspect PCOS-related hair fall, a dermatologist or gynaecologist can order a hormonal panel including total testosterone, free testosterone, DHEA-S, LH/FSH ratio, and anti-Müllerian hormone. An ultrasound confirming polycystic ovaries alongside hormonal markers and clinical symptoms (irregular periods, acne, hirsutism) confirms the diagnosis.

Step 2: Address the systemic hormonal environment

For moderate-to-severe PCOS with significant hyperandrogenism, an endocrinologist may recommend oral contraceptives with anti-androgenic progestin components, spironolactone (an androgen blocker), or metformin for insulin-resistant PCOS. These address the upstream hormonal problem and can meaningfully slow DHT-driven hair loss.

This step requires prescription treatment and medical supervision. No topical product addresses systemic androgen excess.

Step 3: Support the follicle topically

While systemic treatment addresses the hormonal environment, topical actives can protect the follicle from DHT's effect at the scalp level and support the health of existing follicles.

Saw Palmetto (Serenoa repens) is the most researched natural 5-alpha reductase inhibitor — the same enzyme pathway targeted by finasteride and dutasteride, but without systemic hormone disruption. It inhibits approximately 32–38% of 5-alpha reductase activity, reducing DHT availability at the follicle. A 2025 randomised controlled trial confirmed significant improvement in hair density and quality vs placebo.

Procapil partially inhibits DHT through its Oleanolic Acid component while simultaneously strengthening follicle anchoring — addressing both the hormonal and structural aspects of PCOS-related thinning.

Biotin (Vitamin B7) supports keratin production and follicle cell metabolism — important because PCOS is often accompanied by insulin resistance, which disrupts B-vitamin absorption and utilisation.

The Cerise Naturals Anti Hair Fall Serum combines all three — Procapil 2%, Saw Palmetto 2%, Biotin 1%, Anagain 2%, and Keratin 2% — in a lightweight, paraben-free formula applied directly to the scalp daily.

A clinical study on women with PCOS using a targeted hair serum over 6 months showed statistically significant improvements in hair shaft diameter, terminal hair counts, hair growth rate, overall hair fall rate, and hair volume — with the greatest improvements at the 6-month mark, reflecting the time required to see results from follicle-level treatment.

What to Expect and When

PCOS-related hair fall is chronic and progressive if the underlying hormonal imbalance is not addressed. With the right approach:

Month 1–2: Reduction in daily shedding as DHT levels at the follicle are partially managed. Month 2–4: Stabilisation of existing thinning — the hair fall slows significantly. Month 4–6: Improvement in hair shaft diameter and density as follicles in early miniaturisation begin producing fuller hairs. Month 6+: Visible improvement in crown density for most women on a consistent topical + systemic approach.

PCOS hair fall requires patience. The follicle miniaturisation that took months to develop will not reverse in weeks.

The Important Caveat

Topical serums address the follicle-level effects of DHT. They do not treat PCOS itself. If the underlying hormonal imbalance is not managed, the DHT-driven miniaturisation will continue despite the best topical care. The most effective approach combines medical management of PCOS with a consistent topical routine — not one or the other.